GlassScriptPhysician profile
Monique Golding
NPI 1619941119
$3,815.30
in general payments reported to CMS, 2019-2025
36 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $481 · 2021: $801 · 2022: $466 · 2023: $627 · 2024: $318 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $900.75 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $332.39 | 2020-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Amarin Pharma, INC. | $263.18 | 2019-2021 | |
| Pfizer INC. | $229.11 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.30 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $201.39 | 2019-2025 | Mounjaro, Zepbound, Emgality |
| Janssen Pharmaceuticals, INC | $192.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $172.28 | 2019-2023 | |
| Astellas Pharma US INC | $155.69 | 2021-2024 | Veozah |
| E.R. Squibb & Sons, L.L.C. | $143.60 | 2019-2024 | Eliquis |
| Inspire Medical Systems, INC. | $94.00 | 2023-2025 | Inspire |
| Amgen INC. | $91.77 | 2020-2023 | Repatha, Evenity, Prolia |
| Abbvie INC. | $91.76 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $84.53 | 2019-2023 | Farxiga |
| Boston Scientific Corporation | $80.78 | 2021-2025 | General - Erectile Dysfunction, Bodyguardian |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Golding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.